| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Regenxbio Inc. (RGNX) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. RGNX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 495.9K | $4.50M | - | |
| CEO | 342.5K | $3.11M | - | |
| Other | 247.9K | $2.25M | - | |
| Other | 215.4K | $1.95M | - | |
| Other | 82.2K | $745.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 19, 2019 | Mills Kenneth T.81 | President And CEO | Sale+OE | 15,000 | $58.53 | $877,988.90 | -2.9% | |
| Mar 5, 2019 | Vasista Vittal79 | Chief Financial Officer | Sell | 3,068 | $60.01 | $184,110.68 | -1.3% | |
| Feb 25, 2019 | Simpson Curran66 | SVP, Product Development &CTO | Sale+OE | 5,300 | $54.05 | $286,465.00 | -11.8% | |
| Feb 15, 2019 | Mills Kenneth T.81 | President And CEO | Sale+OE | 15,000 | $47.29 | $709,283.56 | -1.9% | |
| Feb 5, 2019 | Simpson Curran66 | SVP, Product Development &CTO | Sale+OE | 43,832 | $50.08 | $2,195,106.56 | -52.6% | |
| Jan 15, 2019 | Mills Kenneth T.81 | President And CEO | Sell | 15,000 | $43.85 | $657,698.00 | -3.6% | |
| Dec 18, 2018 | Christmas Patrick J. | SVP, General Counsel | Sale+OE | 5,000 | $47.54 | $237,697.90 | -30.3% | |
| Dec 17, 2018 | Vasista Vittal79 | Chief Financial Officer | Sell | 7,500 | $46.35 | $347,650.00 | -2.0% | |
| Dec 17, 2018 | Mills Kenneth T.81 | President And CEO | Sell | 15,000 | $46.73 | $700,926.64 | -2.2% | |
| Dec 3, 2018 | Yoo Stephen | Chief Medical Officer | Sale+OE | 20,414 | $60.13 | $1,227,412.43 | -59.2% |